Aminotriazole compounds
US6245916A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2000 |
| Grant date | Jun 12, 2001 |
| Priority date | — |
| Expiry date | Apr 14, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compound of formula (I): ##STR1## wherein: PA1 n is 0 or 1, PA1 W represents --CO-- or S(O).sub.q and q is 0, 1 or 2, PA1 G represents a G.sub.1, G.sub.2, G.sub.3 or G.sub.4 group as defined in the description, PA1 Z represents alkyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkenyl, heteroarylalkynyl or heteroarylalkyl each optionally substituted. PA1 A represents a grouping selected from --A.sub.2 --, --A.sub.1 --A.sub.2 --, --A.sub.2 --A.sub.1 -- and --A.sub.1 --A.sub.2 --A.sub.1 -- wherein A.sub.1 is alkylene and A.sub.2 represents phenylene, cycloalkylene, naphthylene or heteroarylene each optionally substituted, PA1 R represents hydrogen, alkyl, aryl, heteroaryl, arylalkyl arylalkenyl, arylalkynyl, heteroarylakenyl, heteroarylalkynyl or heteroarylalkenyl each optionally substituted, PA1 R.sub.1 represents alkyl, aryl, heteroary, arylalkyl arylalkenyl, arylalkynyl, heteroarylalkenyl, heteroarylalkynyl or heteroarylalkyl each optionally substituted, and medicinal products containing the same which are useful as Neuropeptide Y receptor ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.